Intrauterine drug exposure as a risk factor for cerebral palsy.
Kristen L Benninger, Jessica Purnell, Sara Conroy and 5 others
PMID 34528707WHAT IT FOUND
Infants with intrauterine drug exposure had a 5.2% rate of cerebral palsy, ten times higher than the general population.
Even after excluding very preterm infants, the rate remained significantly elevated. These children warrant high-risk developmental surveillance regardless of other medical complications.
Key findings
01The rate of cerebral palsy in infants with intrauterine drug exposure was 5.2%, significantly higher than the 0.3% found in the general US child population.
02Even when excluding infants born very preterm or those treated for neonatal encephalopathy, the cerebral palsy rate in the drug-exposed group was 3.2%, still ten times higher than the national estimate.
03The type, location, and severity of cerebral palsy in drug-exposed infants were not significantly different from unexposed high-risk infants, suggesting a similar clinical presentation.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was retrospective and relied on chart review, which can lead to missing data or underreporting of exposures, particularly alcohol. The sample was drawn from a specific high-risk NICU follow-up program, which may not represent all infants with drug exposure. The authors could not determine the timing, duration, or dose of drug exposure, nor could they fully account for socioeconomic factors or postnatal environment. Statistical analysis was descriptive and hypothesis-generating; wide confidence intervals mean specific substance risks could not be conclusively determined. Selection bias likely influenced the results, particularly regarding opioid exposure and the apparent 'protective' effect of NOWS treatment.
The easy way to misread this
Do not interpret the non-significant odds ratios for specific substances like barbiturates or cannabis as evidence that they are safe. The study was underpowered to detect differences between individual drugs, and the wide confidence intervals mean these estimates are unreliable. The key finding is the elevated risk associated with intrauterine drug exposure as a broad category.